Hylomorph Overview

  • Founded
  • 2014
  • Status
  • Private
  • Employees
  • 10
  • Latest Deal Type
  • Accelerator/​Inc
  • Investors
  • 8

Hylomorph General Information


Provider of healthcare biomaterials intended to optimize the interface between implantable medical devices and the biological tissues. The company's bio engineered implants interact with the sensing mechanism of cells thus maintaining a healthy interaction between device and tissue, enabling users to improve the quality of life of patients and the quality of care by healthcare professionals.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Other Healthcare Technology Systems
Other Industries
Other Healthcare Services
Primary Office
  • Technoparkstrasse 1
  • 8005 Zurich
  • Switzerland
+41 044 000 00 00

Hylomorph Timeline

Financing RoundFinancing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Hylomorph Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Accelerator/Incubator 31-Jan-2020 00.000 Completed Generating Revenue
6. Secondary Transaction - Private 00.000 Completed Generating Revenue
5. Early Stage VC (Series A) 14-Sep-2018 00.000 00.000 000.00 Completed Generating Revenue
4. Accelerator/Incubator 00000 Completed Startup
3. Accelerator/Incubator 000.00 00000 Completed Startup
2. Early Stage VC 22-Aug-2016 $114K $114K 00.000 Completed Startup
1. Accelerator/Incubator Completed Startup
To view Hylomorph’s complete valuation and funding history, request access »

Hylomorph Cap Table

Stock # of Shares
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Ordinary 000,000 00.00 00.00 00 00.00 00.000
Ordinary 000,000 00.00 00.00 00 00.00 0.00
To view Hylomorph’s complete cap table history, request access »

Hylomorph Executive Team (5)

Name Title Board Seat Contact Info
Simone Bottan Ph.D Co-Founder, Chief Executive Officer & Board Member
Francesco Robotti Chief Operating Officer
Aldo Ferrari Chief Technnical Officer, Chief Scientific Officer & Board Member
Sonia Schmocker Chief Regulatory and Quality Officer
To view Hylomorph’s complete executive team members history, request access »

Hylomorph Board Members (4)

Name Representing Role Since
Aldo Ferrari Hylomorph Chief Technnical Officer, Chief Scientific Officer & Board Member 000 0000
Gian-Luigi Berini Fongit Seed Invest Board Member 000 0000
Peter Gabriel Self Board Member 000 0000
Simone Bottan Ph.D Hylomorph Co-Founder, Chief Executive Officer & Board Member 000 0000
To view Hylomorph’s complete board members history, request access »

Hylomorph Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Hylomorph Investors (8)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
European Commission Government 000 0000 000000 0
Investiere Venture Capital Minority 000 0000 000000 0
StartAngels Network Angel Group Minority 000 0000 000000 0
Zürcher Kantonalbank Corporation Minority 000 0000 000000 0
Wyss Zurich Accelerator/Incubator Minority 000 0000 000000 0
You’re viewing 5 of 8 investors. Get the full list »